Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Disease of Immune System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004192
What this trial is testing

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaNeutropenia
University of Nebraska 60
Large-scale testing (Phase 3)Ended earlyNCT02612311
What this trial is testing

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
TG Therapeutics, Inc. 603
Early research (Phase 1)Study completedNCT00087204
What this trial is testing

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+13 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00435084
What this trial is testing

A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Valerio Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT00081809
What this trial is testing

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Who this might be right for
Lymphoma, FollicularLymphoma, Small Lymphocytic
Agenus Inc. 35
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Not applicableStudy completedNCT05984004
What this trial is testing

Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

Who this might be right for
Rhino Sinusitis
Huro Biotech Joint Stock Company 60
Early research (Phase 1)Study completedNCT06117020
What this trial is testing

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Who this might be right for
Muscle SpasticityHypertonia, MuscleCerebral Palsy+5 more
Motric Bio 89
Not applicableUnknownNCT02271724
What this trial is testing

SCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
University of Aarhus 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06445023
What this trial is testing

Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Celldex Therapeutics 963
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00147901
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
German CLL Study Group 61
Testing effectiveness (Phase 2)UnknownNCT01735604
What this trial is testing

Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT01564277
What this trial is testing

Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+16 more
Roswell Park Cancer Institute 24
Early research (Phase 1)Ended earlyNCT01300611
What this trial is testing

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Who this might be right for
Double Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more
Tarix Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT02234934
What this trial is testing

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

Who this might be right for
Granulomatous Disease, Chronic, X-linked
University of California, Los Angeles 10
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Not applicableStudy completedNCT06939634
What this trial is testing

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

Who this might be right for
Spinal Cord InjuryTetraplegia/TetraparesisParaplegia, Complete+2 more
Wandercraft 35
Post-approval studies (Phase 4)Looking for participantsNCT04589299
What this trial is testing

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
University of Aarhus 60
Very early researchEnded earlyNCT00394316
What this trial is testing

Gene Therapy for Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 3
Next Page